- call +1-201-465-4211
- email sales@mrinsights.biz
A contrast agent (or contrast medium) is a substance used to increase the contrast of structures or fluids within the body in medical imaging.
According to this study, over the next five years the Interventional X-ray Contrast and Imaging Agents market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Interventional X-ray Contrast and Imaging Agents business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Interventional X-ray Contrast and Imaging Agents market by product type, application, key manufacturers and key regions and countries.
This study considers the Interventional X-ray Contrast and Imaging Agents value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Iodinated Contrast Media
Barium-Based Contrast Media
Microbubble Contrast Media
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Heart Disease
Neurological
Urology
General Surgery
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bracco
General Electric
Guerbet
Fujifilm Visualsonics
Imax
J.B. Chemicals & Pharmaceuticals
Jodas Expoim
Lantheus Medical Imaging
Nano Therapeutics
Novalek Pharmaceuticals
Taejoon Pharm
Unijules Life Sciences
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Interventional X-ray Contrast and Imaging Agents consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Interventional X-ray Contrast and Imaging Agents market by identifying its various subsegments.
Focuses on the key global Interventional X-ray Contrast and Imaging Agents manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Interventional X-ray Contrast and Imaging Agents with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Interventional X-ray Contrast and Imaging Agents submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Interventional X-ray Contrast and Imaging Agents Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Interventional X-ray Contrast and Imaging Agents Consumption 2014-2024
2.1.2 Interventional X-ray Contrast and Imaging Agents Consumption CAGR by Region
2.2 Interventional X-ray Contrast and Imaging Agents Segment by Type
2.2.1 Iodinated Contrast Media
2.2.2 Barium-Based Contrast Media
2.2.3 Microbubble Contrast Media
2.2.4 Other
2.3 Interventional X-ray Contrast and Imaging Agents Consumption by Type
2.3.1 Global Interventional X-ray Contrast and Imaging Agents Consumption Market Share by Type (2014-2019)
2.3.2 Global Interventional X-ray Contrast and Imaging Agents Revenue and Market Share by Type (2014-2019)
2.3.3 Global Interventional X-ray Contrast and Imaging Agents Sale Price by Type (2014-2019)
2.4 Interventional X-ray Contrast and Imaging Agents Segment by Application
2.4.1 Heart Disease
2.4.2 Neurological
2.4.3 Urology
2.4.4 General Surgery
2.4.5 Other
2.5 Interventional X-ray Contrast and Imaging Agents Consumption by Application
2.5.1 Global Interventional X-ray Contrast and Imaging Agents Consumption Market Share by Application (2014-2019)
2.5.2 Global Interventional X-ray Contrast and Imaging Agents Value and Market Share by Application (2014-2019)
2.5.3 Global Interventional X-ray Contrast and Imaging Agents Sale Price by Application (2014-2019)
3 Global Interventional X-ray Contrast and Imaging Agents by Manufacturers
3.1 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Manufacturers
3.1.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Manufacturers (2017-2019)
3.1.2 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Manufacturers (2017-2019)
3.2 Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Manufacturers
3.2.1 Global Interventional X-ray Contrast and Imaging Agents Revenue by Manufacturers (2017-2019)
3.2.2 Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Manufacturers (2017-2019)
3.3 Global Interventional X-ray Contrast and Imaging Agents Sale Price by Manufacturers
3.4 Global Interventional X-ray Contrast and Imaging Agents Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
3.4.1 Global Interventional X-ray Contrast and Imaging Agents Manufacturing Base Distribution and Sales Area by Manufacturers
3.4.2 Players Interventional X-ray Contrast and Imaging Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Interventional X-ray Contrast and Imaging Agents by Regions
4.1 Interventional X-ray Contrast and Imaging Agents by Regions
4.1.1 Global Interventional X-ray Contrast and Imaging Agents Consumption by Regions
4.1.2 Global Interventional X-ray Contrast and Imaging Agents Value by Regions
4.2 Americas Interventional X-ray Contrast and Imaging Agents Consumption Growth
4.3 APAC Interventional X-ray Contrast and Imaging Agents Consumption Growth
4.4 Europe Interventional X-ray Contrast and Imaging Agents Consumption Growth
4.5 Middle East & Africa Interventional X-ray Contrast and Imaging Agents Consumption Growth
5 Americas
5.1 Americas Interventional X-ray Contrast and Imaging Agents Consumption by Countries
5.1.1 Americas Interventional X-ray Contrast and Imaging Agents Consumption by Countries (2014-2019)
5.1.2 Americas Interventional X-ray Contrast and Imaging Agents Value by Countries (2014-2019)
5.2 Americas Interventional X-ray Contrast and Imaging Agents Consumption by Type
5.3 Americas Interventional X-ray Contrast and Imaging Agents Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Interventional X-ray Contrast and Imaging Agents Consumption by Countries
6.1.1 APAC Interventional X-ray Contrast and Imaging Agents Consumption by Countries (2014-2019)
6.1.2 APAC Interventional X-ray Contrast and Imaging Agents Value by Countries (2014-2019)
6.2 APAC Interventional X-ray Contrast and Imaging Agents Consumption by Type
6.3 APAC Interventional X-ray Contrast and Imaging Agents Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Interventional X-ray Contrast and Imaging Agents by Countries
7.1.1 Europe Interventional X-ray Contrast and Imaging Agents Consumption by Countries (2014-2019)
7.1.2 Europe Interventional X-ray Contrast and Imaging Agents Value by Countries (2014-2019)
7.2 Europe Interventional X-ray Contrast and Imaging Agents Consumption by Type
7.3 Europe Interventional X-ray Contrast and Imaging Agents Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Interventional X-ray Contrast and Imaging Agents by Countries
8.1.1 Middle East & Africa Interventional X-ray Contrast and Imaging Agents Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Interventional X-ray Contrast and Imaging Agents Value by Countries (2014-2019)
8.2 Middle East & Africa Interventional X-ray Contrast and Imaging Agents Consumption by Type
8.3 Middle East & Africa Interventional X-ray Contrast and Imaging Agents Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Interventional X-ray Contrast and Imaging Agents Distributors
10.3 Interventional X-ray Contrast and Imaging Agents Customer
11 Global Interventional X-ray Contrast and Imaging Agents Market Forecast
11.1 Global Interventional X-ray Contrast and Imaging Agents Consumption Forecast (2019-2024)
11.2 Global Interventional X-ray Contrast and Imaging Agents Forecast by Regions
11.2.1 Global Interventional X-ray Contrast and Imaging Agents Forecast by Regions (2019-2024)
11.2.2 Global Interventional X-ray Contrast and Imaging Agents Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Interventional X-ray Contrast and Imaging Agents Forecast by Type
11.8 Global Interventional X-ray Contrast and Imaging Agents Forecast by Application
12 Key Players Analysis
12.1 Bracco
12.1.1 Company Details
12.1.2 Interventional X-ray Contrast and Imaging Agents Product Offered
12.1.3 Bracco Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Bracco News
12.2 General Electric
12.2.1 Company Details
12.2.2 Interventional X-ray Contrast and Imaging Agents Product Offered
12.2.3 General Electric Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 General Electric News
12.3 Guerbet
12.3.1 Company Details
12.3.2 Interventional X-ray Contrast and Imaging Agents Product Offered
12.3.3 Guerbet Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Guerbet News
12.4 Fujifilm Visualsonics
12.4.1 Company Details
12.4.2 Interventional X-ray Contrast and Imaging Agents Product Offered
12.4.3 Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Fujifilm Visualsonics News
12.5 Imax
12.5.1 Company Details
12.5.2 Interventional X-ray Contrast and Imaging Agents Product Offered
12.5.3 Imax Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Imax News
12.6 J.B. Chemicals & Pharmaceuticals
12.6.1 Company Details
12.6.2 Interventional X-ray Contrast and Imaging Agents Product Offered
12.6.3 J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 J.B. Chemicals & Pharmaceuticals News
12.7 Jodas Expoim
12.7.1 Company Details
12.7.2 Interventional X-ray Contrast and Imaging Agents Product Offered
12.7.3 Jodas Expoim Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Jodas Expoim News
12.8 Lantheus Medical Imaging
12.8.1 Company Details
12.8.2 Interventional X-ray Contrast and Imaging Agents Product Offered
12.8.3 Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Lantheus Medical Imaging News
12.9 Nano Therapeutics
12.9.1 Company Details
12.9.2 Interventional X-ray Contrast and Imaging Agents Product Offered
12.9.3 Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Nano Therapeutics News
12.10 Novalek Pharmaceuticals
12.10.1 Company Details
12.10.2 Interventional X-ray Contrast and Imaging Agents Product Offered
12.10.3 Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Novalek Pharmaceuticals News
12.11 Taejoon Pharm
12.12 Unijules Life Sciences
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Interventional X-ray Contrast and Imaging Agents
Table Product Specifications of Interventional X-ray Contrast and Imaging Agents
Figure Inter
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
